189 related articles for article (PubMed ID: 1648862)
1. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
[TBL] [Abstract][Full Text] [Related]
2. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
[TBL] [Abstract][Full Text] [Related]
3. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
6. Glial fibrillary acidic protein (GFAP) expression and nucleolar organizer regions (NORs) in human gliomas.
Kajiwara K; Orita T; Nishizaki T; Kamiryo T; Nakayama H; Ito H
Brain Res; 1992 Feb; 572(1-2):314-8. PubMed ID: 1319273
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 labelling index in human brain tumours.
Niemiec J
Folia Histochem Cytobiol; 2001; 39(3):259-62. PubMed ID: 11534782
[TBL] [Abstract][Full Text] [Related]
8. Proliferative assessment of GFAP-positive and GFAP-negative glioma cells by nucleolar organizer region staining.
Hara A; Sakai N; Yamada H; Niikawa S; Ohno T; Tanaka T; Mori H
Surg Neurol; 1991 Sep; 36(3):190-4. PubMed ID: 1652162
[TBL] [Abstract][Full Text] [Related]
9. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar organizer regions in vascular and neoplastic cells of human gliomas.
Hara A; Sakai N; Yamada H; Hirayama H; Tanaka T; Mori H
Neurosurgery; 1991 Aug; 29(2):211-5. PubMed ID: 1715979
[TBL] [Abstract][Full Text] [Related]
11. Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferation indices.
Maier H; Morimura T; Ofner D; Hallbrucker C; Kitz K; Budka H
Acta Neuropathol; 1990; 80(2):156-62. PubMed ID: 2389680
[TBL] [Abstract][Full Text] [Related]
12. Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity.
Plate KH; Rüschoff J; Behnke J; Mennel HD
Acta Neurochir (Wien); 1990; 104(3-4):103-9. PubMed ID: 1701284
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. A retrospective study.
Engel U; Plate K; Jänisch W; Mennel HD
Zentralbl Pathol; 1994 Mar; 140(1):73-81. PubMed ID: 7515677
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
Jaros E; Perry RH; Adam L; Kelly PJ; Crawford PJ; Kalbag RM; Mendelow AD; Sengupta RP; Pearson AD
Br J Cancer; 1992 Aug; 66(2):373-85. PubMed ID: 1503912
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study.
Raghavan R; Steart PV; Weller RO
Neuropathol Appl Neurobiol; 1990 Apr; 16(2):123-33. PubMed ID: 2161084
[TBL] [Abstract][Full Text] [Related]
17. AgNOR expression in CNS neoplasms.
Husain N; Bagchi M; Husain M; Tiwari B
Indian J Pathol Microbiol; 1997 Oct; 40(4):503-9. PubMed ID: 9444862
[TBL] [Abstract][Full Text] [Related]
18. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of proliferating potential in human brain tumors by nucleolar organizer region staining on squash preparations.
Hara A; Sakai N; Yamada H; Yoshimi N; Tanaka T; Mori H
J Cancer Res Clin Oncol; 1991; 117(6):510-4. PubMed ID: 1720782
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical evaluation of proliferative activity in human brain tumours.
Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
Anal Cell Pathol; 1990 Sep; 2(5):269-75. PubMed ID: 2275874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
